Market Tracker

11/24 6:05pm ET

Theravance Inc (NASDAQ:THRX)

During the Trading Day
15.20 +1.23 / +8.80%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
15.20 +0.0018 / +0.01%
 
Volume: 13.2K
THRX Regular Dividend: THRX began trading ex-dividend on 11/21/14. A $0.25 dividend will be paid to shareholders of record as of 11/25/14.

Today’s Trading

Previous close13.97
Today’s open14.04
Day’s range13.99 - 15.45
Volume1,148,886
Average volume (3 months)954,594
Market cap$1.6B
Dividend yield6.58%
Data as of 3:59pm ET, 11/24/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+29.51%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+2.90+6.37%
CLVSClovis Oncology Inc-0.32-0.66%
CBPOChina Biologic Produ...+0.98+1.45%
MDCOMedicines Co+0.54+2.10%
Data as of 4:01pm ET, 11/24/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts